2014
DOI: 10.1212/wnl.0000000000000397
|View full text |Cite
|
Sign up to set email alerts
|

Quality improvement in neurology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
14
0
3

Year Published

2014
2014
2023
2023

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 23 publications
(18 citation statements)
references
References 22 publications
1
14
0
3
Order By: Relevance
“…In population-based studies, the prevalence of DSP among patients with confirmed diabetes approaches 25% and is approximately 12% in those with impaired glucose tolerance [25]. Thus, routine screening for diabetes before the full clinical manifestations of the disease will help preventing or slowing the progression of related complications such as diabetic neuropathy [26]. Our findings of an association between increased albuminuria and polyneuropathy are similar to those from the study by Kong et al [27].…”
Section: Risk Factors For Polyneuropathysupporting
confidence: 86%
“…In population-based studies, the prevalence of DSP among patients with confirmed diabetes approaches 25% and is approximately 12% in those with impaired glucose tolerance [25]. Thus, routine screening for diabetes before the full clinical manifestations of the disease will help preventing or slowing the progression of related complications such as diabetic neuropathy [26]. Our findings of an association between increased albuminuria and polyneuropathy are similar to those from the study by Kong et al [27].…”
Section: Risk Factors For Polyneuropathysupporting
confidence: 86%
“…A peripheral neuropathy diagnosis was made after review of patient symptoms and neurological signs and found to be consistent with the accepted parameters to define peripheral neuropathy 10. All patients were seen by a Mayo Clinic neurologist.…”
Section: Methodsmentioning
confidence: 99%
“…In agreement with this assessment, the American Academy of Neurology recently released quality measures for patients with distal symmetric polyneuropathy with 1 of the 6 measures pertaining to falls. 19 Falls should not only be an important outcome measure of future clinical trials, but also a focus of the clinical care of patients with neuropathy.…”
Section: Methodsmentioning
confidence: 99%